有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | methyl 5-[(2R)-2-(2,4-difluorophenyl)sulfanylpropanoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C17H17F2NO3S |
|
—— | N-[2-(4-chlorophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14ClF2NOS |
|
—— | (1R,2R)-1-(3-bromophenyl)-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C14H16BrN3S |
|
—— | N-[(1S)-1-(2-bromophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14BrF2NOS |
|
—— | N-benzyl-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C15H13F2NOS |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-(2,4-difluorophenyl)sulfanylpropanamide | —— | C16H18F2N2OS |
|
—— | N-[(1R)-1-(4-bromophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14BrF2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(1R)-1-phenylethyl]acetamide | —— | C16H15F2NOS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(2R)-2-phenylpropyl]acetamide | —— | C17H17F2NOS |
|
—— | (2R)-2-(2,4-difluorophenyl)sulfanyl-N-[(1R,2S)-2-methylcyclohexyl]propanamide | —— | C16H21F2NOS |
|
—— | N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H13F4NOS |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C16H14ClF2NOS |
|
—— | 2-(2-chlorophenyl)sulfanyl-5-fluoro-N'-hydroxybenzenecarboximidamide | —— | C13H10ClFN2OS |
|
—— | (2R)-N-(1-adamantyl)-2-(2,4-difluorophenyl)sulfanylpropanamide | —— | C19H23F2NOS |
|
—— | (2R)-2-(2,4-difluorophenyl)sulfanyl-N-[2-(4-fluorophenyl)ethyl]propanamide | —— | C17H16F3NOS |
|
—— | 2-[[5-ethyl-4-[(3S)-6-oxopiperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H16N4O3S |
|
—— | (1R,2R)-1-pyridin-3-yl-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C13H16N4S |
|
—— | (1R,2R)-1-(3-methylphenyl)-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C15H19N3S |
|
—— | (2S)-2-(2,4-difluorophenyl)sulfanyl-N-[2-(4-fluorophenyl)ethyl]propanamide | —— | C17H16F3NOS |
|
—— | (1S,2R)-1-pyridin-3-yl-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C13H16N4S |
|
—— | (2S)-2-(2-bromophenyl)-2-pyrimidin-4-ylsulfanylethanamine | —— | C12H12BrN3S |
|
—— | (1R)-1-(3-aminophenyl)-2-pyrimidin-4-ylsulfanylethanol | —— | C12H13N3OS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(1S,2R)-2-methylcyclohexyl]acetamide | —— | C15H19F2NOS |
|
—— | (1S,2S)-1-(5-chlorothiophen-2-yl)-1-pyrimidin-4-ylsulfanylpropan-2-amine | —— | C11H12ClN3S2 |
|
—— | N-[(4-chlorophenyl)methyl]-2-(2,4-difluorophenyl)sulfanylacetamide | —— | C15H12ClF2NOS |
|
—— | (1R,2S)-1-(5-chlorothiophen-2-yl)-1-pyrimidin-4-ylsulfanylpropan-2-amine | —— | C11H12ClN3S2 |
|
—— | 2-[[5-ethyl-4-[(3R)-6-oxopiperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H16N4O3S |
|
—— | 2-[[5-[[(3R)-6-oxopiperidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetic acid | —— | C9H12N4O3S2 |
|
—— | (1R,2S)-1-(3-methylphenyl)-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C15H19N3S |
|
—— | (1S,2S)-1-(3-bromophenyl)-1-pyrimidin-4-ylsulfanylbutan-2-amine | —— | C14H16BrN3S |
|
—— | (1S)-1-(3-aminophenyl)-2-pyrimidin-4-ylsulfanylethanol | —— | C12H13N3OS |
|
—— | 2-[[5-[[(3S)-6-oxopiperidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetic acid | —— | C9H12N4O3S2 |
|
—— | 5-fluoro-N'-hydroxy-2-phenylsulfanylbenzenecarboximidamide | —— | C13H11FN2OS |
|
—— | 2-[4-oxo-1-[(3S)-6-oxopiperidin-3-yl]pyrimidin-2-yl]sulfanylacetic acid | —— | C11H13N3O4S |
|
—— | 2-[4-oxo-1-[(3R)-6-oxopiperidin-3-yl]pyrimidin-2-yl]sulfanylacetic acid | —— | C11H13N3O4S |
|
—— | N-[(1R)-1-(3,4-dimethylphenyl)ethyl]-2-(2-fluorophenyl)sulfanylacetamide | —— | C18H20FNOS |
|
—— | (Z)-[(3E)-3-hydrazinylidene-1-[(S)-methylsulfinyl]-4-[(R)-methylsulfinyl]butan-2-ylidene]hydrazine | —— | C6H14N4O2S2 |
|
—— | 2-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-5-fluoro-N'-hydroxybenzenecarboximidamide | —— | C11H12FN5OS |
|
—— | (Z)-[(3Z)-3-hydrazinylidene-1-[(R)-methylsulfinyl]-4-[(S)-methylsulfinyl]butan-2-ylidene]hydrazine | —— | C6H14N4O2S2 |
|
—— | 3-(3,4-difluorophenyl)sulfanyl-N-[(1S)-1-phenylethyl]propanamide | —— | C17H17F2NOS |
|
—— | (E)-2-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(5-methylthiophen-2-yl)prop-2-enoate | —— | C16H10ClN2O3S2- |
|
—— | 2-[[6-(3,4-difluorophenyl)-5-oxo-4H-1,2,4-triazin-3-yl]sulfanyl]-N-[(1R,2S,3R)-2,3-dimethylcyclohexyl]acetamide | —— | C19H22F2N4O2S |
|
—— | (2S)-2-(4-bromophenyl)-2-pyrimidin-4-ylsulfanylethanamine | —— | C12H12BrN3S |
|
—— | (1S)-1-(4-aminophenyl)-2-pyrimidin-4-ylsulfanylethanol | —— | C12H13N3OS |
|
—— | (1R)-1-(4-aminophenyl)-2-pyrimidin-4-ylsulfanylethanol | —— | C12H13N3OS |
|
—— | (2S)-2-(2-methylphenyl)-2-pyrimidin-4-ylsulfanylethanamine | —— | C13H15N3S |
|
—— | 2-[[6-(3,4-difluorophenyl)-5-oxo-4H-1,2,4-triazin-3-yl]sulfanyl]-N-[(1S,2S,3R)-2,3-dimethylcyclohexyl]acetamide | —— | C19H22F2N4O2S |
|
—— | 2-[[6-(3,4-difluorophenyl)-5-oxo-2H-1,2,4-triazin-3-yl]sulfanyl]-N-[(1S,2S,3S)-2,3-dimethylcyclohexyl]acetamide | —— | C19H22F2N4O2S |
|
—— | (2R)-2-(4-bromophenyl)-2-pyrimidin-4-ylsulfanylethanamine | —— | C12H12BrN3S |
|
—— | 5-fluoro-N'-hydroxy-2-(4-methylpyrimidin-2-yl)sulfanylbenzenecarboximidamide | —— | C12H11FN4OS |
|